Drug Profile
ATON 005
Alternative Names: ATON-005Latest Information Update: 19 Jul 2018
Price :
$50
*
At a glance
- Originator Aton Pharma
- Class Antipsychotics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 16 Jul 2016 No recent reports of development identified for phase-I development in Psychotic-disorders in USA
- 31 May 2010 Phase-I clinical trials in Psychotic disorders in USA (unspecified route)